Home Tags Gene therapy
Tag: gene therapy
We got an inside look at how the biotech Spark used mazes to develop a first-of-its-kind treatment for eye disease on the way to selling itself for $4...
A team of scientists came up with a new way to measure how well a treatment for a rare form of blindness worked.
Elizabeth Warren and Bernie Sanders just slammed the Swiss drug giant Novartis over a new controversy swirling around the world’s most expensive...
"This scandal smacks of the pharmaceutical industry's privilege and greed, and Americans are sick of it," they wrote to the FDA's acting leader.
Aetna and Anthem will now pay for more kids with a devastating rare disease to get a $2.1 million drug, reversing earlier denials
Business Insider's reporting highlighted families fighting for access to the treatment, Zolgensma, which is the most expensive drug in the world.
Dispensed: A big week for digital health IPOs, what happens when a $2.1 million drug can’t get to the kids who need it, and what a top health-te...
Welcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.
‘Like we were being forced to gamble with our son’s life’: Health insurers won’t pay for a $2.1 million drug for kids, and par...
It's "heartbreaking," one mom said, "because this one person is everything to us. And they're acting like his life doesn't really matter."
The US just approved a $2.1 million treatment for a devastating disease. It’s the most expensive drug in the world.
The treatment, called Zolgensma, should last longer than a typical drug. It also has a much higher price tag.
Welcome to Dispensed, Business Insider's weekly newsletter giving you a dose of pharma, biotech, and healthcare news.
Doctors used a cutting-edge medical technique called gene therapy to treat 10 babies born with the disease. The biotech that helped saw its stock surge.
Gene therapy, a decades-old technology that targets disease at its genetic root, is coming of age. New startups are pouring into the space, and it's become a hot area for M&A.
The top scientist at AveXis told us the ‘unique’ strength that powered its $9 billion sale to Novartis, and it could shape the future of g...
Manufacturing has emerged as a huge challenge for the booming gene therapy industry because these products are so new and complex.